Mr. Matthew Head joined OncoNano in 2018 as Chief Financial Officer. Matthew is responsible for OncoNano’s corporate governance, financial oversight and investor relations. He has more than 25 years of experience in the pharmaceutical industry in the U.S. and globally including treasury, investor relations, operational finance, product launches, and mergers and acquisitions. Prior to joining OncoNano, Matthew served as Vice President, Head of Finance at ZS Pharma, Inc., which was acquired by AstraZeneca in 2015. Previously, he was Head of Finance for the U.S. Pharmaceuticals and Consumer Products divisions at Alcon, where he spent 17 years in roles of increasing responsibility. Matthew holds a bachelor’s degree in economics from the University of the South and a master’s degree in business administration from the Neeley School of Business at Texas Christian University.